The development and optimization of a 2nd-Generation process synthesis for the human immunodeficiency virus-1 entry inhibitor CJF-III-288 bis-trufloroacetate salt 1 is reported. The route eliminates the use of noble metals,...
Nadraws et al. (Thu,) studied this question.